PBYI
#2959
Puma Biotechnology Inc - Common Stock
9.0 6 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.95%
Variación mensual
+13.82%
Variación en los últimos 6 meses
+64.43%
Cambio anual
+80.12%
Cierres anteriores
9.2 4
Open
9.0 6
Mínimo
9.0 6
Máximo
9.0 6
Volumen
59
Financials
- Market Capitalization 467.68 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
9.75
Relación precio/flujo de caja
1.32
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +7.99% | +12.82% | 478.97 M USD | ||
| 2954 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +11.59% | +52.17% | 473.65 M USD | ||
| 2968 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.33 USD | -4.20% | -6.68% | -17.21% | +421.69% | 461.88 M USD | ||
| 2980 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | -4.84% | -0.30% | +5.02% | -10.41% | 449.98 M USD |